Sign In
NewsRadar

Press release centre

Search Press
Looking for press releases of a particular company? Enter company name (or keyword) here.
   

Past Press Releases - AM-Pharma BV

May 12, 2015
Pfizer Acquires Minority Interest in AM-Pharma; Secures Option to Acquire Company
Option may be exercised based on Phase II trial results for recombinant human Alkaline Phosphatase. More

September 11, 2014
AM-Pharma Closes €12.2m Financing Round
New capital to complete Phase II development of recAP in Acute Kidney Injury. More

September 23, 2013
AM-Pharma returns to clinic with Phase I trial of new recombinant human Alkaline Phosphatase
AM-Pharma returns to clinic with Phase I trial of new recombinant human Alkaline Phosphatase to treat Acute Kidney Injury. More

December 17, 2009
AM-Pharma announces positive results from its Acute Kidney Injury trial
Positive Phase II trial results confirm observations from earlier Acute Kidney Injury trial. More

March 19, 2009
AM-Pharma announces loan of up to €5 million from Dutch Government
Dutch Government supports AM-Pharma in development of first drug against Acute Kidney Injury More

July 9, 2008
AM-Pharma announces start of second Phase II trial in Acute Renal Failure
Additional Phase II trial aims to confirm earlier positive results More

May 29, 2008
AM-Pharma announces EURO 7 million first close of series C financing round
AM-Pharma B.V., the biopharmaceutical company developing improved endogenous proteins and peptides to combat disease, today announced the signing of a EURO 7 million financing agreement with Forbion Capital Partners and Inventages Venture Capital.
More

September 17, 2007
AM-Pharma announces appointment of Chief Business Officer
AM-Pharma B.V., the biopharmaceutical company developing improved endogenous proteins to combat disease, today announced the appointment of Erik van den Berg as Chief Business Officer. More

August 6, 2007
AM-Pharma announces 2.5 million EURO financing
AM-Pharma B.V., the biopharmaceutical company developing improved endogenous proteins to combat disease, today announced the signing of a 2.5 million Euro financing agreement with its two main investors, Forbion Capital Partners and Inventages Venture Capital. More

July 9, 2007
AM-Pharma announces positive results of Phase IIa clinical trial with Alkaline Phosphatase
AM-Pharma, the biopharmaceutical company developing novel therapeutics to treat infectious and inflammatory diseases, today announced the positive clinical results of its Phase IIa Alkaline Phosphatase trial for patients with ulcerative colitis, a chronic and relapsing inflammatory bowel disease affecting the colon. More

Data


27,871
Tech investments
From our Online Data Service
17,963
VC-backed companies
From our Radar


Recent Deals


DATEAMOUNTSECTOR
Dec 21€50.0MKnowledge management
Dec 20€16.0MSemiconductors
Dec 17€18.0MOther Computers & Electronics
Dec 17€5.2MBiotechnology
Dec 17€17.0MBusiness applications
Dec 15€17.0ME-Commerce
Dec 4€3.3MNanotechnology

For information on Europe's most extensive database on technology funding click here!

Events



Press Releases


Mar 11
Kalysis
the world's most advanced bluetooth key for digital tachographs

Sep 30
TetaVi
tetavi raises $6 million to help more companies bring 3d holograms ...

May 28
Identiq
identiq raises $5m seed, launches privacy-first identity validation...

Apr 29
Nethone
nethone raised over $1 million from innovation nest

Mar 31
CompPair
the fit allocates chf 100'000 to comppair technologies





About usContact usLegal Information
Copyright 1999-2019
Emerging Technology Research Europe Inc. All rights reserved.